The founders of start-up biotech company Chiral Intermediates have an important decision to make. How much money to raise? When? And from what kinds of funding sources? This exercise walks through the market for chiral intermediates (a material that reduces harmful drug side effects), this new company's business model, and its quest for seed-stage financing.

【書誌情報】

ページ数：8ページ

サイズ：A4

商品番号：HBSP-W91C65

発行日：2011/3/22

登録日：2020/3/24